Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market ...

This stock used to be a highflyer but has struggled in recent years as demand waned for its flagship product. Though Moderna ...

International companies are increasingly inking licensing deals with Chinese biotechs as concerns regarding drug pricing and ...

Long-suffering biotech investors might be in for a treat as the SPDR S&P Biotech exchange begins to show signs of renewed ...

Sonnet BioTherapeutics enters into an agreement to transform into the largest U.S.-based publicly listed company to hold HYPE.

Discover why Vertex Pharmaceuticals outperforms amid biotech sector decline. Explore growth drivers, risks, and the ...

Sana Biotechnology, Inc. (NASDAQ:SANA) is among the fundamentally strong penny stocks to invest in. Morgan Stanley has ...

ORLANDO, FL / ACCESS Newswire / July 11, 2025 / RedChip Companies will air interviews with Brag House Holdings, Inc.

Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than three years ago. Indeed, if you axed Moderna off your watchlist after the ...

Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

Glenmark Pharmaceuticals Ltd.’s licensing pact with AbbVie Inc. for its blood cancer drug is boosting optimism over Indian ...